OncoCyte Corp Cash Flow Quality Index
Latest as of March 2023:
-3.19x
OncoCyte Corp cash flow quality index. OncoCyte Corp (OCX) has a Cash Flow Quality Index of -3.19x as of March 2023. Operating cash flow of $-9.67 Million is below net income of $3.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OncoCyte Corp cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-3.19x
Operating CF / Net Income
Operating Cash Flow
$-9.67 Million
USD
Net Income
$3.03 Million
USD
Data as of
Mar 2023
Most recent filing
OncoCyte Corp Cash Flow Quality Index by Year (None–None)
OncoCyte Corp cash flow quality index by year from None to None. Year-by-year earnings quality comparison for OncoCyte Corp. For the full cash flow conversion analysis, see OCX cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.